<DOC>
	<DOCNO>NCT02663999</DOCNO>
	<brief_summary>This single-center , two-period , randomize , open-label , crossover pharmacokinetic ( PK ) study healthy adult volunteer evaluate dose proportionality diazepam nasal spray use two dose level</brief_summary>
	<brief_title>A Pharmacokinetic Study Assess Dose Proportionality , Safety Tolerability Diazepam Nasal Spray Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diazepam</mesh_term>
	<criteria>Screening body weight 88 111 kg , inclusive ; General good health clinically significant abnormality would affect ability complete study determine medical history , physical examination , visual evaluation septum turbinates document baseline anatomy , electrocardiogram , clinical laboratory test result ; Negative drug alcohol testing ; Negative pregnancy test female subject childbearing potential . Subject surgically sterile female subject le 2 year postmenopausal , agree use highly effective birth control method study 3 month last dose investigational product ; In judgment Investigator , clinically significant abnormality ( septal perforation ) illness would interfere participation study determine medical history , physical examination ( include visual exam septum turbinate ) , ECG , clinical laboratory result , screen safety test ; Any condition and/or situation cause investigator deem subject unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>dose proportionality</keyword>
	<keyword>diazepam nasal spray</keyword>
</DOC>